- This event has passed.
PCO Accept Webinar: Do you know how motivated patients affected by multiple sclerosis are to take treatment & why they are not?
June 15, 2017 @ 10:00 - 11:00 UTC+0
Benoit Arnould, PhD - Senior Director, Patient-Centered Outcomes (PCO), Patient-Centered Sciences (PCS), Mapi Group
Sandra Wiederkehr, PhD - Project Director, Direct to Patient Contact (DPC), Patient-Centered Sciences (PCS), Mapi Group
Michael Chekroun - CEO/Founder of Carenity
Marc Latellier - Carenity
Did you know that 25% of European patients treated for MS are poorly adherent to their medication? Did you know that the MS population was below average in terms of treatment acceptance? Adherence and persistence are concerns for industry but… - How do you communicate the value of convenience to payors and HTA? - How do you help doctors identify and overcome barriers to adherence? - How do you get patient’s honest feedback about your drugs and your competitors’? - How do you identify accurately what sort of innovation is needed to address unmet needs?
On June 15th, I'll be co-hosting a Patient-Centered Outcomes Webinar on this topic, exploring results from the APTEO study - a real-world multi-country study assessing adherence and acceptance in 576 patients affected by multiple sclerosis. Our results not only shed unbiased light on the magnitude of the adherence and acceptance issues in MS, they also explain why. We uncover the precise issues patients experience with the major treatments on the market.
If lack of adherence or persistence is a painpoint for you, if you struggle to communicate the value of therapeutic innovation to your stakeholders, this webinar will give you the reliable information you need to act on solutions.